Reports by Industry

Diagnostics Market Reports

Diagnostics Market Reports

Global Cancer Cell Analysis Market Size, Trends & Analysis - Forecasts to 2029 By Application (Cancer Research Centers, Cancer Hospital, Surgical Centers, and Clinics), By Product (Instruments and Consumables), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global cancer cell analysis market is estimated to exhibit a CAGR of 8.3% from 2024 to 2029. Read More »
November 15 : 2024

Global T-cell Therapy Market Size, Trends & Analysis - Forecasts to 2029 By Therapy Type (CAR T-cell Therapy, T Cell Receptor (TCR)-based, and Tumor Infiltrating Lymphocytes (TIL)-based), By Process Step (Hematologic Malignancies [Lymphoma, Leukemia, and Myeloma], Solid Tumors [Melanoma, Brain & Central Nervous System, Liver Cancer, and Others], and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global T-cell therapy market is estimated to exhibit a CAGR of 36.1% from 2024 to 2029. Read More »
October 28 : 2024

Global Concierge Medicine Market Size, Trends & Analysis - Forecasts to 2029 By Application (Cardiology, Primary Care, Psychiatry, Pediatrics, Osteopathy, Neurology, and Others), By Ownership (Group and Standalone), By End User (Individuals, Corporate Organizations, and Government Agencies), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global concierge medicine market is estimated to exhibit a CAGR of 9.5% from 2024 to 2029. Read More »
May 21 : 2024

Global Viral Sepsis Diagnostics Market Size, Trends & Analysis - Forecasts to 2029 By Diagnostic Method (Molecular Diagnostics, Serological Testing, Point-of-Care Testing, and Others), By Virus Type (Influenza Virus, Respiratory Syncytial Virus (RSV), Herpes Simplex Virus (HSV), Human Immunodeficiency Virus (HIV), Hepatitis Viruses (HCV, HBV), Dengue Virus, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global viral sepsis diagnostics market is estimated to exhibit a CAGR of 9.4% from 2024 to 2029. Read More »
May 15 : 2024

Global PCR & Real-time PCR Molecular Diagnostics Market Size, Trends & Analysis - Forecasts to 2029 By Technology (Traditional PCR, Real-time PCR, and Digital PCR), By Application (Infectious Disease Testing, Oncology Testing, Genetic Testing, and Others), By End User (Hospitals, Diagnostic Laboratories, Academic & Research Centers, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global polymerase chain reaction (PCR) & real-time PCR molecular diagnostics market is estimated to exhibit a CAGR of 4.3% from 2024 to 2029. Read More »
May 8 : 2024

Global Photodynamic Therapy Market Size, Trends & Analysis - Forecasts to 2029 By Product (Photosensitizer Drugs and Photodynamic Therapy Devices), By Application (Cancer, Actinic Keratosis, Acne, Psoriasis, and Others), By End User (Hospitals, Cancer Treatment Centers, Cosmetic and Dermatology Clinics, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global photodynamic therapy (PDT) market is estimated to exhibit a CAGR of 8.4% from 2024 to 2029. Read More »
May 7 : 2024

Global Self-Amplifying mRNA Vaccines Market Size, Trends & Analysis - Forecasts to 2029 By Target Disease (COVID-19, Influenza, Cancer (e.g., Melanoma, Breast Cancer), and Other Infectious Diseases), By Development Phase (Preclinical, Clinical (Phase I, II, III), and Commercialized), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global self-amplifying mRNA vaccines (SMA) market is analyzed to grow at a CAGR of 2.7% during the forecast period from 2024 to 2029. Read More »
May 2 : 2024

Global Gene Therapy for Spinal Muscular Atrophy Market Size, Trends & Analysis - Forecasts to 2029 By Therapy Type (AAV-based Gene Therapy and Lentiviral vector-based Gene Therapy), By Development Phase (Preclinical, Clinical (Phase I, II, III), and Commercialized), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global gene therapy for spinal muscular atrophy (SMA) market is analyzed to grow at a CAGR of 7.6% during the forecast period from 2024 to 2029. Read More »
May 2 : 2024

Global Exon Skipping Drugs Market Size, Trends & Analysis - Forecasts to 2029 By Therapeutic Indication (Duchenne Muscular Dystrophy (DMD) and Other Genetic Disorders), By Exon Target (Exon 51 Skipping, Exon 53 Skipping, Exon 45 Skipping, and Other Exon Targets), By Phase of Development (Preclinical, Clinical (Phase I, II, III), and Approved), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global exon skipping drugs market is analyzed to grow at a CAGR of 40.8% during the forecast period from 2024 to 2029. Read More »
May 2 : 2024

Global Next-Generation CAR T Cell Therapies Market Size, Trends & Analysis - Forecasts to 2029 By Type of Therapy (Allogeneic Therapies, Autologous Therapies, and Others), By Targeted Indications (Hematologic Malignancies and Solid Tumors), By Development Phase (Preclinical, Clinical (Phase I, II, III), and Commercialized), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global next-generation CAR T cell therapies market is projected to grow at a CAGR of 33.1% from 2024 to 2029. Read More »
April 30 : 2024